Latest filing published 14 Mar 2011 for Chemtura CORP.
No signal scores available.
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Roger L. Headrick is a declared insider at 3 companies; the most frequent names are CVS HEALTH Corp, Chemtura Corp and Caremark RX Inc. In total, 24 filings cover trades dated from 24 January 2006 to 10 March 2011.
The open-market record is one-sided, with 5 purchases worth €248k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 10 share grants and 2 option exercises.
In size, the median ticket on the buying side is €64k. For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -5.3%. Past outcomes like these are no guarantee of what comes next.
On 14 March 2011 came the latest disclosure, a share grant in Chemtura Corp. The last insider purchase was made public on 24 May 2007, 7,092 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations